Chapter 22. Evaluating Strategies For Risk Assessment of Nanomaterials

  1. Saura C. Sahu3 and
  2. Daniel A. Casciano4
  1. Nastassja Lewinski1,
  2. Huiguang Zhu2 and
  3. Rebekah Drezek1

Published Online: 18 AUG 2009

DOI: 10.1002/9780470747803.ch22



How to Cite

Lewinski, N., Zhu, H. and Drezek, R. (2009) Evaluating Strategies For Risk Assessment of Nanomaterials, in Nanotoxicity (eds S. C. Sahu and D. A. Casciano), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470747803.ch22

Editor Information

  1. 3

    Division of Toxicology, Center for Food Safety and Applied Nutrition, Food and Drug Administration, 8301 Muirkirk Road, Laurel, MD 20708, USA

  2. 4

    Department for Applied Science, University of Arkansas at Little Rock, Little Rock, AR, USA

Author Information

  1. 1

    Rice University, Department of Bioengineering MS-142, Houston, TX 77005, USA

  2. 2

    Rice University, Department of Chemistry MS-60, Houston, TX 77005, USA

Publication History

  1. Published Online: 18 AUG 2009
  2. Published Print: 21 AUG 2009

ISBN Information

Print ISBN: 9780470741375

Online ISBN: 9780470747803



  • evaluating strategies for nanomaterial risk assessment;
  • National Research Council (NRC);
  • hazard assessment and dose-response assessment;
  • nanomaterial environmental, health and safety data;
  • nanomaterials escaping macrophage phagocytosis and endocytosis;
  • potential hazard of nanomaterial translocation after dermal absorption;
  • dose and toxicity for pharmaceuticals;
  • current nanomaterial risk assessment limitations;
  • American National Standards Institute (ANSI);
  • medical applications of nanomaterials and dose monitoring


This chapter contains sections titled:

  • Introduction

  • What is Risk Assessment?

  • Current Status of Nanomaterial Environmental, Health and Safety Data

  • Uncertainties in Nanomaterial Risk Assessment and Current Efforts to Address these Challenges

  • Conclusion

  • Acknowledgements

  • References